Task: Answer the multiple-choice question.
Question: Which compound exhibits a -2.373% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC(C)N1CCc2c(sc(NC(=O)Cc3ccccc3)c2C#N)C1.Cl
b CCOC(=O)c1csc(NC(=O)CSc2nnnn2CC)n1
c Brc1ccc(OCc2nnc3n2CCC3)cc1
Answer: b. CCOC(=O)c1csc(NC(=O)CSc2nnnn2CC)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1csc(NC(=O)CSc2nnnn2CC)n1
CCOC(=O)c1csc(NC(=O)CSc2nnnn2CC)n1
ethyl 2-[[2-(1-ethyltetrazol-5-yl)sulfanylacetyl]amino]-1,3-thiazole-4-carboxylate